Respiratory syncytial virus (RSV) can cause serious respiratory infections, second only to
influenza virus. In order to know RSV's genetic changes we examined 4028 respiratory …

Respiratory syncytial virus (RSV) is a very frequent viral respiratory pathogen of the young (<
5 years old) with a significant portion of young toddlers having been infected before 2 years …

Respiratory viral infections contribute significantly to morbidity and mortality worldwide, but
representative data from sub-Saharan Africa are needed to inform vaccination strategies …

Respiratory syncytial virus (RSV) is a major pathogen that infects lower respiratory tract and
causes a common respiratory disease. Despite serious pathological consequences with this …

Respiratory syncytial virus (RSV) is among the most common causes of lower respiratory
tract infection among infants and the elderly worldwide. Despite its long history, no licensed …

Introduction: Respiratory infections have an enormous, worldwide epidemiologic impact on
humans and animals. Among the prophylactic measures, vaccination has the potential to …

The respiratory syncytial virus (RSV) causes significant respiratory disease in young infants
and the elderly. Immune prophylaxis in infants is currently limited to palivizumab, an anti …

The limited antiviral options and lack of an effective vaccine against human respiratory
syncytial virus (RSV) highlight the need for a novel antiviral therapy. One alternative is to …

Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and hospitalization
that lead to high morbidity and mortality among young infants. T helper 17 (Th17) cells and …

Background and Purpose Protease‐activated receptor 1 (PAR1) has been demonstrated to
be involved in the pathogenesis of viral diseases. However, its role remains controversial …